Department of Gastroenterology, Mie General Medical Center, Yokkaichi, 510-8561, Japan.
Department of Surgery, Mie General Medical Center, Yokkaichi, 510-8561, Japan.
BMC Gastroenterol. 2022 Jun 25;22(1):313. doi: 10.1186/s12876-022-02382-y.
Gut pathological microbial imbalance or dysbiosis is closely associated with colorectal cancer. Although there are observable differences in molecular and clinical characteristics between patients with right- and left-sided colon cancer, differences in their gut microbiomes have not been thoroughly investigated. Furthermore, subsequent changes in microbiota status after partial colectomy remain unknown. We examined the human gut microbiota composition to determine its relationship with colon cancer and partial colon resection according to location.
Stool samples from forty-one subjects (10 in the control group, 10 in the right-sided colon cancer [RCC] group, 6 in the sigmoid colon cancer [SCC] group, 9 in the right colon resection [RCR] group and 6 in the sigmoid colon resection [SCR] group) were collected, and DNA was extracted. After terminal restriction fragment length polymorphism (T-RFLP) analysis, the samples were subjected to 16S rRNA gene amplicon sequencing, and the metabolic function of the microbiota was predicted using PICRUSt2.
T-RFLP analysis showed a reduced ratio of clostridial cluster XIVa in the SCC patients and clostridial cluster IX in the RCC patients, although these changes were not evident in the RCR or SCR patients. 16S rRNA gene amplicon sequencing demonstrated that the diversity of the gut microbiota in the RCC group was higher than that in the control group, and the diversity in the SCR group was significantly higher than that in the RCR group. Principal coordinate analysis (PCoA) revealed significant differences according to the group. Analyses of the microbiota revealed that Firmicutes was significantly dominant in the RCC group and that the SCC group had a higher abundance of Verrucomicrobia. At the genus level, linear discriminant analysis effect size (LEfSe) revealed several bacteria, such as Ruminococcaceae, Streptococcaceae, Clostridiaceae, Gemellaceae, and Desulfovibrio, in the RCC group and several oral microbiomes in the SCC group. Metabolic function prediction revealed that cholesterol transport- and metabolism-related enzymes were specifically upregulated in the RCC group and that cobalamin metabolism-related enzymes were downregulated in the SCC group.
Gut microbial properties differ between RCC and SCC patients and between right hemicolectomy and sigmoidectomy patients and may contribute to clinical manifestations.
肠道病理微生物失衡或失调与结直肠癌密切相关。尽管右半结肠癌和左半结肠癌患者在分子和临床特征上存在明显差异,但他们的肠道微生物组之间的差异尚未得到彻底研究。此外,部分结肠切除术后微生物状态的后续变化尚不清楚。我们检查了人类肠道微生物群落的组成,以根据位置确定其与结肠癌和部分结肠切除的关系。
收集 41 名受试者(对照组 10 名,右半结肠癌[RCC]组 10 名,乙状结肠癌[SCC]组 6 名,右结肠切除术[RCR]组 9 名,乙状结肠切除术[SCR]组 6 名)的粪便样本,并提取 DNA。经末端限制性片段长度多态性(T-RFLP)分析后,对样本进行 16S rRNA 基因扩增子测序,并使用 PICRUSt2 预测微生物代谢功能。
T-RFLP 分析显示,SCC 患者的梭菌簇 XIVa 比例降低,RCC 患者的梭菌簇 IX 比例降低,但 RCR 或 SCR 患者的这些变化并不明显。16S rRNA 基因扩增子测序显示,RCC 组肠道微生物多样性高于对照组,SCR 组显著高于 RCR 组。主坐标分析(PCoA)显示组间存在显著差异。微生物分析显示,RCC 组Firmicutes 明显占优势,SCC 组Verrucomicrobia 丰度较高。在属水平上,线性判别分析效应量(LEfSe)揭示了 RCC 组中的一些细菌,如 Ruminococcaceae、Streptococcaceae、Clostridiaceae、Gemellaceae 和 Desulfovibrio,以及 SCC 组中的一些口腔微生物。代谢功能预测显示,RCC 组胆固醇转运和代谢相关酶特异性上调,SCC 组钴胺素代谢相关酶下调。
RCC 和 SCC 患者以及右半结肠切除术和乙状结肠切除术患者的肠道微生物特性不同,可能与临床表现有关。